pfe

    By Melly Alazraki

    | 3:00PM 9/02/2009
    Pfizer Inc. (PFE) claimed yet another record Wednesday. This honor, dubious at best, came about when the pharmaceutical giant agreed to pay a record $2.3 billion to settle civil and criminal charges over marketing of its recalled Bextra arthritis drug and three other medicines. Kathleen Sebelius,...

    By Melly Alazraki

    | 7:30PM 8/12/2009
    If the story of Pfizer (PFE)'s Neurontin epilepsy and anti-seizure drug doesn't read like a Hollywood script for the next George Clooney movie, I don't know what does. From shady company practices to lawsuits to a mystery donation to a media battle between lawyers and Pfizer's CEO to a former CIA...

    By Tim Catts

    | 4:30PM 7/28/2009
    Stocks fell slightly today as an unexpectedly poor reading from the Conference Board's gauge of consumer confidence outweighed the news that home prices in the nation's 20 biggest markets posted a monthly increase for the first time in three years. The Dow Jones Industrial Average dropped 12...

    By James Cullen

    | 1:45PM 7/20/2009
    Wyeth (WYE) shareholders "have voted overwhelmingly" in favor of selling the company to Pfizer (PFE), according to an AP news item. The $68 billion deal made headlines in January when it was announced amidst terrible conditions in global stock and credit markets. The combined company will be the...

    By Melly Alazraki

    | 3:00PM 7/02/2009
    Elan Corp. (ELN)'s share price popped over 20 percent earlier today, but by the afternoon was up "only" over 13 percent. Still, not bad at all considering markets are down about 2 percent. The Irish drugmaker and Johnson & Johnson (JNJ) announced today they have signed a deal giving J&J...

    By Melly Alazraki

    | 1:30PM 7/02/2009
    It's hard to keep up with the Obama-era Food and Drug Administration. Within the past two weeks alone, the FDA warned that Zicam cold remedy could damage the sense of smell, took aim at lowering the maximum daily dose of acetaminophen, and Wednesday ordered Pfizer Inc (PFE) and GlaxoSmithKline PLC...

    By Tim Catts

    | 4:30PM 6/16/2009
    Sometimes it's obvious when news moves the markets. And sometimes it's a bit harder to tell. But when Reuters published a story late this afternoon quoting New York University professor Nouriel Roubini saying that "in addition to green shoots there are also yellow weeds" threatening any nascent...

    By Tim Catts

    | 4:30PM 6/15/2009
    Investors seemed to remember that the world economy is in the throes of a deep recession today, as commodities fell, the dollar and U.S. Treasury bonds rose and the Dow Jones industrial average plunged 187 points, or 2.1 percent, to close at 8,612. American Express (AXP) and Microsoft (MSFT) were...

    By Melly Alazraki

    | 3:00PM 6/02/2009
    GlaxoSmithKline (GSK) and Concert Pharmaceuticals, a Massachusetts-based start-up company, announced today that they will collaborate to develop and commercialize deuterium-containing medicines. Concert is a clinical stage biotechnology company focused on the application of deuterium chemistry....

    By Melly Alazraki

    | 1:30PM 5/26/2009
    Biotechnology company United Therapeutics Corp. (UTHR) announced today it has received a Food and Drug Administration approval for Adcirca, once-a-day 40 mg tablets for the treatment of pulmonary arterial hypertension (PAH). PAH is a progressive, life-threatening disease in which the pressure in a...